Retractable Technologies (RVP) Net Income towards Common Stockholders (2010 - 2026)
Retractable Technologies (RVP) reported Net Income towards Common Stockholders of -$4.3 million for Q1 2026, up 59.44% on a YoY basis from -$2.7 million in Q1 2025, and down 78.03% quarter-over-quarter from -$2.4 million in Q4 2025.
Retractable Technologies (RVP) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Retractable Technologies has reported Net Income towards Common Stockholders for 17 years, with the latest figure at -$4.3 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 59.44% year-over-year to -$4.3 million; the trailing twelve-month figure through Mar 2026 stood at -$6.5 million (up 71.71% YoY), and the FY2025 full-year result was -$12.8 million, down 5.6% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$4.3 million, down from -$2.4 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $7.6 million in Q1 2022, with the low at -$14.2 million in Q2 2024.
- Historically, Net Income towards Common Stockholders has averaged -$1.9 million across 5 years, with a median of -$2.0 million in 2024.
- Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders jumped 2944.05% — and 2025, when it sank 2939.99%.
- Retractable Technologies' Net Income towards Common Stockholders stood at -$4.3 million in 2022, then jumped by 96.99% to -$130557.0 in 2023, then jumped by 2944.05% to $3.7 million in 2024, then slumped by 164.79% to -$2.4 million in 2025, then plunged by 78.03% to -$4.3 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$4.3 million (Q1 2026), -$2.4 million (Q4 2025), and $313436.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.00 Mn |
| 10 | Retractable Technologies | 19.78 Mn | -15.84 Mn | -838,408.00 | -4.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.28 Mn |
| Dec 31, 2025 | -2.41 Mn |
| Sep 30, 2025 | 313,436.00 |
| Jun 30, 2025 | -145,082.00 |
| Mar 31, 2025 | -10.56 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | -1.98 Mn |
| Jun 30, 2024 | -14.22 Mn |
| Mar 31, 2024 | 371,773.00 |
| Dec 31, 2023 | -130,557.00 |
| Sep 30, 2023 | -4.12 Mn |
| Jun 30, 2023 | -3.93 Mn |
| Mar 31, 2023 | 932,861.00 |
| Dec 31, 2022 | -4.34 Mn |
| Sep 30, 2022 | 5.33 Mn |
| Jun 30, 2022 | -3.70 Mn |
| Mar 31, 2022 | 7.56 Mn |
| Dec 31, 2021 | 20.87 Mn |
| Sep 30, 2021 | 6.46 Mn |
| Jun 30, 2021 | 10.60 Mn |